.. Diagnostic-positif, 15 a) Histoire clinique, p.15

.. Situations-particulières, 23 a), p.23

C. Du-venin-pour-la-désensibilisation and .. , 24 a) Tests cutanés et IgE spécifiques positifs pour un seul venin, p.24

.. Critères-d-'inclusion, 28 a) Le diagnostic positif, p.28

K. Hunt, M. Valentine, A. Sobotka, A. Benton, F. Amodio et al., A Controlled Trial of Immunotherapy in Insect Hypersensitivity, New England Journal of Medicine, vol.299, issue.4, pp.157-161, 1978.
DOI : 10.1056/NEJM197807272990401

U. Müller, U. Thurnheer, R. Patrizzi, J. Spiess, and R. Hoigné, Immunotherapy in Bee Sting Hypersensitivity., Allergy, vol.55, issue.6, pp.369-378, 1979.
DOI : 10.1016/0091-6749(77)90169-5

D. Golden, K. Johnson, B. Addison, M. Valentine, A. Kagey-sobotka et al., Clinical and immunologic observations in patients who stop venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.77, issue.3, pp.435-442, 1986.
DOI : 10.1016/0091-6749(86)90177-6

U. Müller, A. Helbling, and E. Berchtold, Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety, Journal of Allergy and Clinical Immunology, vol.89, issue.2, pp.529-535, 1992.
DOI : 10.1016/0091-6749(92)90319-W

R. Ross, H. Nelson, and I. Finegold, Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysis, Clinical Therapeutics, vol.22, issue.3, pp.351-358, 2000.
DOI : 10.1016/S0149-2918(00)80039-9

F. Ruëff, A. Wenderoth, and B. Przybilla, Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses, Journal of Allergy and Clinical Immunology, vol.108, issue.6, pp.1027-1032, 2001.
DOI : 10.1067/mai.2001.119154

S. Brown, M. Wiese, K. Blackman, and R. Heddle, Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial, The Lancet, vol.361, issue.9362, pp.1001-1006, 2003.
DOI : 10.1016/S0140-6736(03)12827-9

J. Moffitt, D. Golden, R. Reisman, R. Lee, R. Nicklas et al., Stinging insect hypersensitivity: A practice parameter update, Journal of Allergy and Clinical Immunology, vol.114, issue.4, pp.869-886, 2004.
DOI : 10.1016/j.jaci.2004.07.046

F. Bonifazi, M. Jutel, B. Biló, J. Birnbaum, and U. Muller, Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice, Allergy, vol.60, issue.1, pp.1459-1470, 2005.
DOI : 10.4049/jimmunol.166.5.3612

J. Bousquet, J. Menardo, and F. Michel, Allergies aux venins d'hyménoptères. Joinville-Le-Pont, Institut Français de Recherche en Allergologie, p.112, 1985.

D. Hoffman and R. Jacobson, Allergens in hymenoptera venom XII: how much protein is in a sting? Ann Allergy, avr, vol.52, issue.4, pp.276-278, 1984.

B. Biló, F. Rueff, H. Mosbech, F. Bonifazi, and J. Oude-elberink, Diagnosis of Hymenoptera venom allergy, Allergy, vol.101, issue.74, pp.1339-1388, 2005.
DOI : 10.1046/j.1365-2222.1997.980914.x

J. Bousquet, U. Müller, S. Dreborg, R. Jarisch, H. Malling et al., Immunotherapy with Hymenoptera venoms., Allergy, vol.73, issue.6, pp.401-414, 1987.
DOI : 10.1016/0091-6749(80)90118-9

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.1987.tb00355.x/pdf

F. Wr and L. Mh, Wasp venom allergy and immunity, Ann Allergy. oct, vol.14, issue.5, pp.347-366, 1956.

L. Lichtenstein, M. Valentine, and A. Sobotka, A Case for Venom Treatment in Anaphylactic Sensitivity to Hymenoptera Sting, New England Journal of Medicine, vol.290, issue.22, pp.1223-1227, 1974.
DOI : 10.1056/NEJM197405302902204

W. Busse, C. Reed, L. Lichtenstein, and R. Reisman, Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom, JAMA: The Journal of the American Medical Association, vol.231, issue.11, pp.1154-1156, 1975.
DOI : 10.1001/jama.231.11.1154

R. Reisman, D. Dvorin, C. Randolph, and J. Georgitis, Stinging insect allergy: Natural history and modification with venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.75, issue.6, pp.735-740, 1985.
DOI : 10.1016/0091-6749(85)90103-4

D. Golden, Insect sting allergy and venom immunotherapy: A model and a mystery, Journal of Allergy and Clinical Immunology, vol.115, issue.3, pp.439-447, 2005.
DOI : 10.1016/j.jaci.2005.01.005

M. Severino, P. Bonadonna, and G. Passalacqua, Large local reactions from stinging insects: from epidemiology to management, Current Opinion in Allergy and Clinical Immunology, vol.9, issue.4, pp.334-337, 2009.
DOI : 10.1097/ACI.0b013e32832d0668

P. Lieberman, R. Nicklas, J. Oppenheimer, S. Kemp, D. Lang et al., The diagnosis and management of anaphylaxis practice parameter: 2010 Update, Journal of Allergy and Clinical Immunology, vol.126, issue.3, pp.477-480, 2010.
DOI : 10.1016/j.jaci.2010.06.022

B. Bilò and F. Bonifazi, Epidemiology of insect-venom anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.8, issue.4, pp.330-337, 2008.
DOI : 10.1097/ACI.0b013e32830638c5

E. Novembre, A. Cianferoni, R. Bernardini, M. Veltroni, A. Ingargiola et al., Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.68, issue.10, pp.834-838, 1998.
DOI : 10.1016/0091-6749(81)90133-0

U. Müller, Bee venom allergy in beekeepers and their family members, Current Opinion in Allergy and Clinical Immunology, vol.5, issue.4, pp.343-347, 2005.
DOI : 10.1097/01.all.0000173783.42906.95

M. Bilò and F. Bonifazi, The natural history and epidemiology of insect venom allergy: clinical implications, Clinical & Experimental Allergy, vol.39, issue.10, pp.1467-76, 2009.
DOI : 10.1111/j.1365-2222.2009.03324.x

S. Pucci, L. Antonicelli, M. Bilò, M. Garritani, and F. Bonifazi, Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy, Allergy, vol.25, issue.10, pp.894-896, 1994.
DOI : 10.1016/0091-6749(78)90231-2

J. Bousquet, Y. Coulomb, M. Robinet-levy, and F. Michel, Clinical and immunological surveys in bee keepers, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.36, issue.4, pp.331-342, 1982.
DOI : 10.1016/0091-6749(80)90118-9

B. Chipps, M. Valentine, A. Kagey-sobotka, K. Schuberth, and L. Lichtenstein, Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children, The Journal of Pediatrics, vol.97, issue.2, pp.177-184, 1980.
DOI : 10.1016/S0022-3476(80)80470-7

S. Blum, A. Gunzinger, U. Müller, and A. Helbling, Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings, Allergy, vol.64, issue.2, pp.222-228, 2011.
DOI : 10.1111/j.1398-9995.2010.02470.x

F. Ruëff, B. Przybilla, M. Biló, U. Müller, F. Scheipl et al., Clinical Effectiveness of Hymenoptera Venom Immunotherapy: A Prospective Observational Multicenter Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, PLoS ONE, vol.116, issue.5, p.63233, 2013.
DOI : 10.1371/journal.pone.0063233.t002

F. Ruëff, B. Przybilla, M. Biló, U. Müller, F. Scheipl et al., Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase???a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, Journal of Allergy and Clinical Immunology, vol.124, issue.5, pp.1047-1054, 2009.
DOI : 10.1016/j.jaci.2009.08.027

L. Antonicelli, M. Bilò, G. Napoli, B. Farabollini, and F. Bonifazi, European hornet (Vespa crabro) sting: a new risk factor for life-threatening reaction in hymenoptera allergic patients?, Eur Ann Allergy Clin Immunol. juin, vol.35, issue.6, pp.199-203, 2003.

U. Mueller, Cardiovascular disease and anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.7, issue.4, pp.337-341, 2007.
DOI : 10.1097/ACI.0b013e328259c328

P. Greenberger, B. Rotskoff, and B. Lifschultz, Fatal anaphylaxis: postmortem findings and associated comorbid diseases, Annals of Allergy, Asthma & Immunology, vol.98, issue.3, pp.252-257, 2007.
DOI : 10.1016/S1081-1206(10)60714-4

G. Marone, M. Bova, A. Detoraki, A. Onorati, F. Rossi et al., The human heart as a shock organ in anaphylaxis, Novartis Found Symp, vol.257, pp.133-149, 2004.

U. Müller, Hymenoptera venom anaphylaxis and cardiovascular disease, Der Hautarzt, vol.12, issue.3, pp.206-208, 2008.
DOI : 10.1016/0140-6736(92)93314-D

K. White and R. England, Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy, Annals of Allergy, Asthma & Immunology, vol.101, issue.4, pp.426-430, 2008.
DOI : 10.1016/S1081-1206(10)60321-3

D. Lang, Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy? Curr Allergy Asthma Rep, mars, vol.8, issue.1, pp.37-44, 2008.

F. Ruëff, M. Placzek, and B. Przybilla, Mastocytosis and Hymenoptera venom allergy, Current Opinion in Allergy and Clinical Immunology, vol.6, issue.4, pp.284-288, 2006.
DOI : 10.1097/01.all.0000235903.10548.63

K. Brockow, C. Jofer, H. Behrendt, and J. Ring, Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients, Allergy, vol.17, issue.1 part 1, pp.226-232, 2008.
DOI : 10.1001/archderm.1962.01590080087011

M. Niedoszytko, J. De-monchy, J. Van-doormaal, E. Jassem, O. Elberink et al., Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy, Allergy, vol.110, issue.9, pp.1237-1245, 2009.
DOI : 10.1016/S1081-1206(10)60305-5

P. Vadas, M. Gold, B. Perelman, G. Liss, G. Lack et al., Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis, New England Journal of Medicine, vol.358, issue.1, pp.28-35, 2008.
DOI : 10.1056/NEJMoa070030

P. Vadas, B. Perelman, and G. Liss, Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis, Journal of Allergy and Clinical Immunology, vol.131, issue.1, pp.144-149, 2013.
DOI : 10.1016/j.jaci.2012.08.016

P. Coombs and P. Gell, Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical aspects of immunology. Oxford (UK): Oxford University Pess: Gell RR editors, pp.575-596, 1968.

K. Takeuchi, Anti-inflammatory Effect of Glyteer, Journal of Pharmacological Sciences, vol.149, issue.157, 1990.

H. Mueller, Diagnosis and Treatment of Insect Sensitivity, Journal of Asthma Research, vol.177, issue.4, pp.331-333, 1966.
DOI : 10.1056/NEJM195908202610803

M. Krishna, P. Ewan, L. Diwakar, S. Durham, A. Frew et al., Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines, Clinical & Experimental Allergy, vol.107, issue.(S, pp.1201-1221, 2011.
DOI : 10.1067/mai.2001.111852

R. Brehler, S. Grundmann, and B. Stöcker, Cross-reacting carbohydrate determinants and hymenoptera venom allergy, Current Opinion in Allergy and Clinical Immunology, vol.13, issue.4, pp.360-364, 2013.
DOI : 10.1097/ACI.0b013e328362c544

U. Müller, Insect sting allergy--clinical aspects, diagnosis and therapy], Wien Med Wochenschr. 15 avr, vol.139, pp.6-7150, 1989.

U. Müller, N. Johansen, A. Petersen, J. Fromberg-nielsen, and G. Haeberli, venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5, Allergy, vol.61, issue.4, pp.543-548, 2009.
DOI : 10.1159/000234924

P. Wachholz and S. Durham, Mechanisms of immunotherapy: IgG revisited, Current Opinion in Allergy and Clinical Immunology, vol.4, issue.4, pp.313-318, 2004.
DOI : 10.1097/01.all.0000136753.35948.c0

G. Kanny, A. Croizier, J. Ragazzini, and D. Moneret-vautrin, Suivi immunologique des désensibilisations aux venins d'hyménoptères. Intérêt du test de Maunsell. Revue Française d'Allergologie et d'Immunologie Clinique, oct, vol.33, issue.4, pp.274-283, 1993.
DOI : 10.1016/s0335-7457(05)80046-2

B. Eberlein-könig, J. Rakoski, H. Behrendt, and J. Ring, Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy, J Investig Allergol Clin Immunol, vol.14, issue.1, pp.10-16, 2004.

P. Korosec, R. Erzen, M. Silar, N. Bajrovic, P. Kopac et al., Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results, Clinical & Experimental Allergy, vol.39, issue.11, pp.1730-1737, 2009.
DOI : 10.1111/j.1365-2222.2009.03347.x

U. Müller, H. Mosbech, P. Blaauw, S. Dreborg, H. Malling et al., Emergency treatment of allergic reactions to Hymenoptera stings, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.42, issue.3, pp.281-288, 1991.
DOI : 10.1016/0091-6749(85)90103-4

L. Lichtenstein, N. Holtzman, and L. Burnett, A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody, J Immunol. août, vol.101, issue.2, pp.317-324, 1968.

L. Lichtenstein, P. Norman, and W. Winkenwerder, Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever, The American Journal of Medicine, vol.44, issue.4, pp.514-524, 1968.
DOI : 10.1016/0002-9343(68)90052-1

D. Golden, D. Meyers, A. Kagey-sobotka, M. Valentine, and L. Lichtenstein, Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy, Journal of Allergy and Clinical Immunology, vol.69, issue.6, pp.489-493, 1982.
DOI : 10.1016/0091-6749(82)90172-5

R. Aalberse, F. Van-milligen, K. Tan, and S. Stapel, Allergen-specific IgG4 in atopic disease, Allergy, vol.166, issue.87, pp.559-569, 1993.
DOI : 10.1093/infdis/165.6.1158

O. Elberink, J. Van-der-heide, S. Guyatt, G. Dubois, and A. , Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings, Clinical & Experimental Allergy, vol.39, issue.6, pp.883-889, 2009.
DOI : 10.1111/j.1365-2222.2009.03230.x

H. Schwartz, D. Golden, and R. Lockey, Venom immunotherapy in the Hymenoptera-allergic pregnant patient, Journal of Allergy and Clinical Immunology, vol.85, issue.4, pp.709-712, 1990.
DOI : 10.1016/0091-6749(90)90188-A

G. Haeberli, M. Brönnimann, T. Hunziker, and U. Müller, Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.52, issue.9, pp.1216-1220, 2003.
DOI : 10.1034/j.1398-9995.1999.t01-1-00882.x

O. Elberink, J. De-monchy, J. Kors, J. Van-doormaal, J. Dubois et al., Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis, Journal of Allergy and Clinical Immunology, vol.99, issue.1, pp.153-154, 1997.
DOI : 10.1016/S0091-6749(97)70314-2

P. Bonadonna, R. Zanotti, M. Pagani, B. Caruso, O. Perbellini et al., How much specific is the association between hymenoptera venom allergy and mastocytosis?, Allergy, vol.113, issue.9, pp.1379-1382, 2009.
DOI : 10.1111/j.1398-9995.2007.01569.x

U. Müller and G. Haeberli, Use of ??-blockers during immunotherapy for Hymenoptera venom allergy, Journal of Allergy and Clinical Immunology, vol.115, issue.3, pp.606-610, 2005.
DOI : 10.1016/j.jaci.2004.11.012

D. Golden, A. Kagey-sobotka, P. Norman, R. Hamilton, and L. Lichtenstein, Insect sting allergy with negative venom skin test responses, Journal of Allergy and Clinical Immunology, vol.107, issue.5, pp.897-901, 2001.
DOI : 10.1067/mai.2001.114706

A. Goldberg and R. Confino-cohen, Timing of venom skin tests and IgE determinations after insect sting anaphylaxis, Journal of Allergy and Clinical Immunology, vol.100, issue.2, pp.182-184, 1997.
DOI : 10.1016/S0091-6749(97)70222-7

D. Golden, J. Tracy, T. Freeman, and D. Hoffman, Negative venom skin test results in patients with histories of systemic reaction to a sting, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.495-498, 2003.
DOI : 10.1016/S0091-6749(03)01537-9

R. Reisman, Guidelines for management of people with histories of insect sting anaphylaxis and subsequent negative venom skin tests, Journal of Allergy and Clinical Immunology, vol.113, issue.2, p.364, 2004.
DOI : 10.1016/j.jaci.2003.11.028

J. Birnbaum, D. Charpin, and D. Vervloet, Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols, Clinical & Experimental Allergy, vol.3, issue.3, pp.226-230, 1993.
DOI : 10.1111/j.1365-2222.1991.tb01659.x

A. Roll, G. Hofbauer, B. Ballmer-weber, and P. Schmid-grendelmeier, Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy, J Investig Allergol Clin Immunol, vol.16, issue.2, pp.79-85, 2006.

G. Pasaoglu, B. Sin, and Z. Misirligil, Rush hymenoptera venom immunotherapy is efficacious and safe, J Investig Allergol Clin Immunol, vol.16, issue.4, pp.232-238, 2006.

V. Patella, G. Florio, A. Giuliano, C. Oricchio, G. Spadaro et al., Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol, Journal of Allergy, vol.91, issue.4, 2012.
DOI : 10.1016/S1081-1206(10)61689-4

J. Birnbaum, M. Ramadour, A. Magnan, and D. Vervloet, Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.323, issue.1, pp.58-64, 2003.
DOI : 10.1056/NEJM199012063232305

E. Berchtold, R. Maibach, and U. Müller, Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.34, issue.6, pp.59-65, 1992.
DOI : 10.1016/0091-6749(86)90405-7

K. Brockow, M. Kiehn, C. Riethmüller, D. Vieluf, J. Berger et al., Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial??????????????????, Journal of Allergy and Clinical Immunology, vol.100, issue.4, pp.458-463, 1997.
DOI : 10.1016/S0091-6749(97)70135-0

U. Muller, Y. Hari, and E. Berchtold, Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy, Journal of Allergy and Clinical Immunology, vol.107, issue.1, pp.81-86, 2001.
DOI : 10.1067/mai.2001.111852

D. Golden, Practical Considerations in Venom Immunotherapy, Allergy and Asthma Proceedings, vol.18, issue.2, pp.79-83, 1997.
DOI : 10.2500/108854197778605518

H. Mosbech and U. Müller, Side-effects of insect venom immunotherapy:results from an EAACI multicenter study, Allergy, vol.98, issue.11, pp.1005-1010, 2000.
DOI : 10.1016/S0091-6749(96)70224-5

R. Boyle, M. Elremeli, J. Hockenhull, M. Cherry, M. Bulsara et al., Venom immunotherapy for preventing allergic reactions to insect stings, Cochrane Database of Systematic Reviews, vol.49, issue.4, p.8838, 2012.
DOI : 10.1111/j.1398-9995.1994.tb02660.x

A. Watanabe, L. Fonseca, C. Galvão, K. J. Castro, and F. , Specific immunotherapy using Hymenoptera venom: systematic review, Sao Paulo Medical Journal, vol.110, issue.1, pp.30-37, 2010.
DOI : 10.1067/mai.2002.125827

URL : http://www.scielo.br/pdf/spmj/v128n1/07.pdf

J. Hockenhull, M. Elremeli, M. Cherry, J. Mahon, M. Lai et al., A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen?? for the treatment of bee and wasp venom allergy., Health Technology Assessment, vol.16, issue.12, pp.1-110, 2012.
DOI : 10.3310/hta16120

W. Light, Insect sting fatality 9 years after venom treatment (venom allergy, fatality), Journal of Allergy and Clinical Immunology, vol.107, issue.5, p.925, 2001.
DOI : 10.1067/mai.2001.114985

C. Ponvert and P. Scheinmann, Quoi de neuf dans l'allergie aux venins d'hyménoptères ? Une revue critique de la littérature récente, 2000.
DOI : 10.1016/s0335-7457(01)00089-2

D. Golden, K. Kwiterovich, A. Kagey-sobotka, and L. Lichtenstein, Discontinuing venom immunotherapy: Extended observations??????????????????, Journal of Allergy and Clinical Immunology, vol.101, issue.3, pp.298-305, 1998.
DOI : 10.1016/S0091-6749(98)70239-8

D. Golden, A. Kagey-sobotka, and L. Lichtenstein, Survey of patients after discontinuing venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.105, issue.2, pp.385-390, 2000.
DOI : 10.1016/S0091-6749(00)90092-7

D. Golden, Fatal insect allergy after discontinuation of venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.107, issue.5, pp.925-926, 2001.
DOI : 10.1067/mai.2001.115095

U. Müller and E. Lerch, Duration of venom immunotherapy, J Allergy Clin Immunol. févr, vol.99, issue.2, pp.271-272, 1997.

E. Lerch and U. Müller, Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patients??????????????????, Journal of Allergy and Clinical Immunology, vol.101, issue.5, pp.606-612, 1998.
DOI : 10.1016/S0091-6749(98)70167-8

D. Golden, Long-term outcome after venom immunotherapy, Current Opinion in Allergy and Clinical Immunology, vol.10, issue.4, pp.337-341, 2010.
DOI : 10.1097/ACI.0b013e32833bc0ba

D. Golden, J. Moffitt, R. Nicklas, T. Freeman, D. Graft et al., Stinging insect hypersensitivity: A practice parameter update 2011, Journal of Allergy and Clinical Immunology, vol.127, issue.4, pp.852-854, 2011.
DOI : 10.1016/j.jaci.2011.01.025

A. Koterba and P. Greenberger, Chapter 4: Stinging insect allergy and venom immunotherapy, Allergy and Asthma Proceedings, vol.33, issue.3, pp.12-14, 2012.
DOI : 10.2500/aap.2012.33.3534